15-May-2025 6:00 AM CST - Business Wire Bruker Announces Quarterly Dividend $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Companys common stock. The dividend will be paid on June 27, 2025 to stockholders of record as of June 16, 2025. About Bruker Corporation Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new app
7-May-2025 6:00 AM CST - Business Wire Bruker Reports First Quarter 2025 Financial Results $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2025. Frank H. Laukien, Brukers President and CEO, commented: Bruker had a solid start to 2025 with double-digit reported and CER revenue growth, 5.1% organic revenue growth in our BSI segment, and better operating margin performance than expected - all on strong execution, despite uncertainties in key markets. In Q1 and April, we launched key products i
11-Apr-2025 7:00 AM CST - Business Wire Bruker Announces First Quarter 2025 Preliminary Revenue $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $800 million, comparing favorably to the Companys earlier outlook and well ahead of consensus. This estimated range implies reported revenue growth of approximately 10% year-over-year, with low-double digit percentage constant exchange rate revenue growth. Bruker estimates non-GAAP organic revenue growth in the first
21-Feb-2025 6:00 AM CST - Business Wire Bruker Announces Quarterly Dividend $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Companys common stock. The dividend will be paid on March 28, 2025 to stockholders of record as of March 17, 2025. About Bruker Corporation Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new a
20-Feb-2025 3:01 PM CST - Business Wire Bruker Corporation to Present at Upcoming Investor Conferences $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Citi 2025 Unplugged Medtech and Life Sciences Access Day in New York City Thursday, February 27, 2025, at 2:30 p.m. Eastern Time TD Cowen 45th Annual Health Care Conference in Boston, MA Wednesday, March 5, 2025, at 11:10 a.m. Eastern Time Barclays 27th Annual Global Healthcare Conference in Miami, FL Tuesday, March 11, 2025, at 2:30 p.m. Eas
7-Feb-2025 6:00 AM CST - Business Wire Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the Q4 2024 Earnings Webcast hyperlink in the Events & Presentat
7-Jan-2025 3:05 PM CST - Business Wire Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 13th, 2025 at 3:45 PM Pacific Standard Time. A live audio webcast of the presentation will
18-Nov-2024 6:00 AM CST - Business Wire Bruker Announces Quarterly Dividend $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Companys common stock. The dividend will be paid on December 16, 2024 to stockholders of record as of December 2, 2024. About Bruker Corporation Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop
12-Nov-2024 6:00 AM CST - Business Wire Bruker Corporation to Present at Upcoming Investor Conferences $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences: Stifel 2024 Healthcare Conference in New York City Monday, November 18, 2024, at 8:35 a.m. Eastern Time Wolfe Research 2024 Healthcare Conference in New York City Tuesday, November 19, 2024, at 4:10 p.m. Eastern Time Nasdaq 51st Investor Conference in London, UK Tuesday, December 1
15-May-2025 6:00 AM CST - Business Wire Bruker Announces Quarterly Dividend $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Companys common stock. The dividend will be paid on June 27, 2025 to stockholders of record as of June 16, 2025. About Bruker Corporation Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new app
7-May-2025 6:00 AM CST - Business Wire Bruker Reports First Quarter 2025 Financial Results $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2025. Frank H. Laukien, Brukers President and CEO, commented: Bruker had a solid start to 2025 with double-digit reported and CER revenue growth, 5.1% organic revenue growth in our BSI segment, and better operating margin performance than expected - all on strong execution, despite uncertainties in key markets. In Q1 and April, we launched key products i
11-Apr-2025 7:00 AM CST - Business Wire Bruker Announces First Quarter 2025 Preliminary Revenue $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $800 million, comparing favorably to the Companys earlier outlook and well ahead of consensus. This estimated range implies reported revenue growth of approximately 10% year-over-year, with low-double digit percentage constant exchange rate revenue growth. Bruker estimates non-GAAP organic revenue growth in the first
21-Feb-2025 6:00 AM CST - Business Wire Bruker Announces Quarterly Dividend $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Companys common stock. The dividend will be paid on March 28, 2025 to stockholders of record as of March 17, 2025. About Bruker Corporation Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new a
20-Feb-2025 3:01 PM CST - Business Wire Bruker Corporation to Present at Upcoming Investor Conferences $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Citi 2025 Unplugged Medtech and Life Sciences Access Day in New York City Thursday, February 27, 2025, at 2:30 p.m. Eastern Time TD Cowen 45th Annual Health Care Conference in Boston, MA Wednesday, March 5, 2025, at 11:10 a.m. Eastern Time Barclays 27th Annual Global Healthcare Conference in Miami, FL Tuesday, March 11, 2025, at 2:30 p.m. Eas
7-Feb-2025 6:00 AM CST - Business Wire Bruker Announces Date and Time of Fourth Quarter 2024 Earnings Release and Webcast $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the Q4 2024 Earnings Webcast hyperlink in the Events & Presentat
7-Jan-2025 3:05 PM CST - Business Wire Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 13th, 2025 at 3:45 PM Pacific Standard Time. A live audio webcast of the presentation will
18-Nov-2024 6:00 AM CST - Business Wire Bruker Announces Quarterly Dividend $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Companys common stock. The dividend will be paid on December 16, 2024 to stockholders of record as of December 2, 2024. About Bruker Corporation Leader of the Post-Genomic Era (Nasdaq: BRKR) Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop
12-Nov-2024 6:00 AM CST - Business Wire Bruker Corporation to Present at Upcoming Investor Conferences $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences: Stifel 2024 Healthcare Conference in New York City Monday, November 18, 2024, at 8:35 a.m. Eastern Time Wolfe Research 2024 Healthcare Conference in New York City Tuesday, November 19, 2024, at 4:10 p.m. Eastern Time Nasdaq 51st Investor Conference in London, UK Tuesday, December 1
